This week, we released our updated summary of MHRA’s regulatory guidance for medicines. This substantial update follows the numerous changes to guidance since implementation of the Windsor Framework in January 2025.
The results are in from our latest annual membership survey, and we’re excited to share that once again, we have received a 100% overall satisfaction rate with our membership.
We are pleased to announce that Bas Vorsteveld and Rob Elliot have both been appointed as new Vice-Presidents to PAGB’s Board, as well as welcoming Simon Wade as PAGB's new Honorary Treasurer.
We're pleased to share our 2024 Highlights Report, which sets out our key work across the last year on behalf of our members across the consumer healthcare industry.
Ahead of International Women's Day, TAF, CBI and FSB have once again joined forces to champion the role of Women in trade bodies, and have recognised two members of the PAGB team.
To mark his inauguration as PAGB President, Mike Knowland, General Manager for Northern Europe at Bayer Consumer Health, gave an interview to P3Pharmacy all about PAGB’s work to champion self-care and shift healthcare for self-treatable conditions closer to patients and community pharmacy.
A summary report of a formal complaint from Opella regarding claims for Movicol Ease in consumer and professional advertising.
We are pleased to hear the news that the Medicines and Healthcare products Regulatory Agency (MHRA) has today appointed Lawrence Tallon as CEO.
PAGB's Deputy CEO takes us through the third of our strategic pillars in PAGB's new 5-year strategy: Promoting best practice.
We’re pleased to share with PAGB members a new edition of our Professional Code for Medicines Advertising.
The Conditions and Categories working group - a workstream of the Reclassification Alliance - shares a joint statement on DHSC's reclassification announcement.
PAGB is pleased to support an announcement shared by the Department of Health and Social Care (DHSC) which issues a list of medical conditions and categories where it is encouraging more reclassification applications to the Medicines and Healthcare products Regulatory Agency (MHRA).
We support journalists and media with information and guidance about branded OTC medicines, medical devices and food supplements.
Learn moreAre you a member who would like to receive regular updates and news from PAGB? Subscribe to our weekly newsletters.
Learn moreFollow PAGB on LinkedIn for our latest posts, news and updates.
Learn more